HopeStage
Back to all studies
CompletedNCT03142919

Inflammatory Challenge and Brain Responses in Major Depression

About this titleRead the official source — NCT03142919
Placebo comparisonAges 18–55United States
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 7, 2017
Recruitment status
Completed
Enrollment listed in the registry
64
Sponsor
Laureate Institute for Brain Research, Inc.
Sponsor type
Research institute
Study type
Biological
Intervention type
Biological
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT03142919
Official title
Show the full official title

Response to Inflammatory Challenge in Major Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Tulsa

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Laureate Institute for Brain Research, Inc., a research institute.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies